Metoprolol Succinate Tablet, Extended Release
Product Images NDC 60760-634

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 60760-634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Meto (Metoprolol 60760 634 90)

Meto (Metoprolol 60760 634 90)
Label for metoprolol succinate extended-release tablets, USP 50 mg, with a quantity of 90 tablets. The label includes NDC 60760-634-90, manufacturer Cadila Healthcare Ltd., Ahmedabad, India, and packaging by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. Instructions indicate to use as directed and store at controlled room temperature 15°-30°C (59°-86°F). Several fields for lot number, expiration date, and RX number are represented with question marks.*
FDA Label Image

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 01)

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 01)
Chemical structure of metoprolol succinate showing the molecular components of metoprolol and succinate ions as indicated by the product data for metoprolol succinate extended-release tablets.*
FDA Label Image

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 02)

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 02)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' depicting the relative risk and 95% confidence intervals for metoprolol succinate versus placebo across multiple subgroups. The chart includes three panels comparing total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure, with subgroup categories listed vertically (e.g., US, Non-US, NYHA classes, sex, ethnicity). Each panel shows markers and horizontal lines indicating risk ratio estimates and confidence intervals favoring either metoprolol succinate or placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.